Skip to main content
Clinical Trials/NCT01442922
NCT01442922
Completed
Not Applicable

Intervertebral Disc Nucleus Augmentation With Allograft Meniscus With Minimally Invasive Surgical Procedure

University of Florida1 site in 1 country1 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Degenerative Disc Disease
Sponsor
University of Florida
Enrollment
1
Locations
1
Primary Endpoint
Visual Analog Scale (VAS) documentation of the level of back pain. The (VAS) will describe the change in the level of back pain from the pre-op level.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The primary purpose of the study is to establish the degree and duration of pain relief following minimally invasive surgery for a painful degenerative disc.

Detailed Description

The investigators will study patient recovery (outcome measures) in patients who have had minimally invasive surgery for implantation of human meniscus allograft (HMA) to replace the nucleus pulposus of a degenerative intervertebral disc.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
December 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of degenerative disk disease at L3-L4, L4-L5, or L5-S1
  • low back for no more that one year prior to enrollment

Exclusion Criteria

  • Osteoporosis
  • Degenerative changes of vertebral endplates (obvious fractures, osteophytes)
  • Modic Type II changes indicative of advanced bony degeneration
  • Facet arthrosis (loss of facet joint cartilage, increased synovial fluid collection, or presence of osteophytes in inferior or superior plates)
  • Discs classified with stage I or II degeneration
  • Patients unable to have an MRI (pacemaker, claustrophobia, etc.)

Outcomes

Primary Outcomes

Visual Analog Scale (VAS) documentation of the level of back pain. The (VAS) will describe the change in the level of back pain from the pre-op level.

Time Frame: Patients will complete the (VAS) at pre-op and at 6 wks. and at 3, 6, 12, and 24 mos. post-operatively.

Patients will complete the (VAS) pre-operatively and post-operatively at 6 wks, and 3, 6, 12, and 24 mos. Responses are expressed on a ten centimeter line, with 0 representing no pain and 10cm representing the worst pain possible. The patient places a mark across the line representing where their perceived pain lies, from no pain to severe pain.

Secondary Outcomes

  • The Oswestry Low Back Pain Disability Questionnaire (OLBPQ) function assessment The (OLBPQ) will describe the change in the level of function from the pre-op level.(Patients will complete the (OLBPQ) at pre-op and at 6 wks. and at 3, 6, 12, and 24 mos. post-operatively.)

Study Sites (1)

Loading locations...

Similar Trials